CN Patent

CN109456400A — 胰高血糖素类似物

Assigned to Zealand Pharma AS · Expires 2019-03-12 · 7y expired

What this patent protects

本发明涉及胰高血糖素类似物及其医疗用途，例如在治疗低血糖中的用途。特别地，本发明涉及适于以液体制剂使用的稳定的胰高血糖素类似物。

USPTO Abstract

本发明涉及胰高血糖素类似物及其医疗用途，例如在治疗低血糖中的用途。特别地，本发明涉及适于以液体制剂使用的稳定的胰高血糖素类似物。

Drugs covered by this patent

dasiglucagon-hydrochloride (DASIGLUCAGON HYDROCHLORIDE)

Patent Metadata

Patent number: CN109456400A
Jurisdiction: CN
Classification: —
Expires: 2019-03-12
Drug substance claim: No
Drug product claim: No
Assignee: Zealand Pharma AS
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.